Conditions: Anemia
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 200
Healthy volunteers: no

Brief summary:
This study will evaluate the efficacy and safety of subcutaneous (SC) epoetin beta in anemic participants with breast cancer undergoing chemotherapy.

Detailed description:

Arms:
arm 1: Anemic breast cancer participants will receive epoetin beta treatment for 12 weeks.

Interventions: intervention 1: Epoetin Beta
Intervention descriptions: intervention 1: All participants will receive epoetin beta at a dose of 30000 International Units (IU) as SC injection once every week for a total of 12 weeks. Adjustments in the dose will be implemented based on the participant's blood hemoglobin levels.

Protocol document: